EDOF Lenses and Visual Field Defects
How Visual Field Defects Affect Lens Selection
Visual field defects are areas of reduced or lost vision in your peripheral or central visual field. Glaucoma is the most common cause, damaging the optic nerve and creating blind spots that can expand over time. Other causes include stroke, retinal conditions, and optic nerve disorders. Your eye doctor maps these defects using visual field testing (perimetry) to determine their location, size, and severity.
The type and location of your field defect matters for IOL selection. Central field defects, which affect the area you use for reading and recognizing faces, have the greatest impact on premium IOL performance. Peripheral defects that spare central fixation may allow more flexibility in lens choice because the optical center of the IOL still functions in healthy visual territory.
Premium IOLs like EDOF and multifocal designs distribute light across multiple focal zones, reducing the total light delivered to each zone. According to Glaucoma Australia and Glaucoma Today (2019), EDOF IOLs are generally contraindicated in patients with advanced glaucoma or central visual field defects because both premium IOLs and glaucoma independently reduce contrast sensitivity. Combining both in the same eye can push contrast below a functional threshold.
Patients with field loss already use their remaining visual capacity under strain. Adding a lens that further reduces contrast can make daily tasks like reading, navigating stairs, and recognizing faces more difficult rather than easier. Your surgeon evaluates whether the extended range of an EDOF lens outweighs the contrast cost for your specific field status.
Contrast sensitivity measures your ability to distinguish objects from their background, especially in dim lighting or low-contrast situations. Glaucoma reduces contrast sensitivity by damaging the nerve fibers that carry visual information from your retina to your brain. Premium IOLs reduce it further by splitting light. When both factors combine, the resulting contrast level may fall below what you need for comfortable daily function.
Your surgeon measures your contrast sensitivity as part of the preoperative evaluation for premium IOLs. This measurement, combined with your visual field test results, helps determine whether your remaining visual system can support the optical trade-offs of an EDOF lens or whether a monofocal IOL would preserve more usable contrast for your daily activities.
When EDOF IOLs Can Help Patients with Field Loss
According to a 2024 study published in PMC, patients with mild glaucoma and a mean deviation (MD) of-10 dB or betterwith no central fixation loss have shown effective visual rehabilitation with EDOF IOLs. These patients retain enough healthy nerve fiber and contrast reserve to benefit from the extended range that EDOF provides without experiencing a meaningful decline in visual quality.
A separate 2024 PMC study confirmed favorable outcomes with EDOF IOLs in patients with primary open-angle glaucoma that was medically controlled and had no central field involvement. These results suggest that mild, stable glaucoma does not automatically exclude patients from premium IOL options, provided their central visual function is well preserved.
Patients with visual field defects limited to the peripheral areas, such as superior arcuate scotomas with intact inferior hemifields, have reported clinical success with EDOF IOLs. According to Review of Ophthalmology, these patients retain the central visual processing capacity needed for the EDOF lens to function as designed. The lens performs its distance-to-intermediate focal work in the healthy central zone while the peripheral defect does not interfere with the optical system.
Your surgeon reviews your visual field map to determine whether your central fixation is spared and stable. If your central field has been reliable for at least six to twelve months with no progression, your surgeon may consider EDOF as a reasonable option that adds intermediate range beyond what a monofocal would provide.
According to a 2024 study published by Dovepress (PMC), non-diffractive EDOF IOLs cause less light scatter than diffractive designs and may be safer for patients with mild glaucoma. Non-diffractive EDOF lenses use wavefront-shaping technology rather than concentric diffractive rings to extend the depth of focus. This approach preserves more contrast sensitivity because less light is lost to scatter within the lens optics.
A 2024 PMC study confirmed that non-diffractive EDOF IOL outcomes in patients with well-controlled glaucoma and ocular hypertension showed favorable uncorrected distance and intermediate visual acuity. Your surgeon may specifically recommend a non-diffractive EDOF design if your glaucoma status places you on the borderline between monofocal and premium IOL candidacy.
When a Monofocal Lens Is the Safer Choice
If your visual field testing shows central scotomas, dense arcuate defects extending into fixation, or advanced overall field loss, a monofocal IOL delivers the maximum contrast and light to your remaining functional retina. Your eye doctor may recommend a monofocal lens set for distance, paired with reading glasses for near tasks. This combination avoids any additional contrast reduction from premium lens optics.
Patients with advanced glaucoma often have limited visual reserve, meaning even a small reduction in contrast sensitivity can affect their ability to perform daily tasks. Preserving the highest possible contrast with a monofocal lens is the most conservative and predictable approach for protecting your remaining visual function.
If your glaucoma is progressing despite treatment, or if your visual field tests show worsening over the past six to twelve months, your surgeon may advise against any premium IOL. A progressing disease means your future visual field could look different from today's, and a lens choice that works now might become less appropriate as the disease advances. Monofocal IOLs remain reliable regardless of how the surrounding disease progresses.
Your glaucoma specialist and cataract surgeon collaborate on the timing and lens selection for your surgery. If your eye pressure is not yet stable on medication, your surgeon may recommend achieving better pressure control before proceeding with cataract surgery and premium IOL consideration.
If preoperative testing reveals that your contrast sensitivity is already below normal thresholds, even a mild glaucoma patient may do better with a monofocal IOL. The contrast sensitivity measurement gives your surgeon an objective data point beyond what the visual field alone shows. Patients with reduced contrast sensitivity and a premium IOL may struggle more with daily tasks than patients with the same contrast who receive a monofocal lens.
Your surgeon factors contrast sensitivity into the overall decision alongside your field test results, optic nerve imaging, intraocular pressure history, and your personal visual priorities. No single test determines the recommendation, but contrast sensitivity testing provides practical information about how your vision functions in real-world conditions.
The Evaluation and Decision Process
Your eye doctor performs a Humphrey visual field test (or equivalent automated perimetry) to map your field defects in detail. According to Glaucoma Today (2019), standard visual field testing and OCT nerve fiber analysis should be completed before IOL selection in glaucoma patients. The field test shows the location, depth, and pattern of any scotomas, while OCT reveals the structural health of your optic nerve fibers.
Your surgeon reviews both recent and historical field tests to determine whether your defects are stable or progressing. Stability over the past six to twelve months is a key factor in deciding whether a premium IOL is appropriate for your situation.
In addition to visual field testing, your surgeon may measure your contrast sensitivity using standardized charts and order macular OCT scans to evaluate the health of your central retina. These tests complement the field test by assessing functional visual quality rather than just the boundaries of your visual field. A patient with mild field loss but good contrast sensitivity is a stronger EDOF candidate than a patient with the same field loss but poor contrast.
Your surgeon combines all of these data points into a comprehensive picture of your visual system. The goal is matching the IOL to your current functional vision while leaving a safety margin for any future changes in your glaucoma status.
If you have both a glaucoma specialist and a cataract surgeon, they coordinate on your lens recommendation. Your glaucoma specialist provides information about your disease trajectory, treatment status, and long-term prognosis. Your cataract surgeon translates this into a lens selection that maximizes your visual range without compromising your remaining visual function.
You are part of this conversation. Your surgeon explains the specific trade-offs of each lens option for your particular visual field pattern and asks about your daily visual priorities. Some patients prefer the broader range of EDOF even with slightly reduced contrast, while others prefer the security of maximum contrast with a monofocal lens and reading glasses.
Questions About EDOF Lenses and Visual Field Defects
Patients with mild, stable glaucoma and intact central visual fields may be candidates for EDOF IOLs. Patients with advanced glaucoma or central field defects are better served by monofocal IOLs. Your surgeon and glaucoma specialist evaluate your specific situation to determine which lens is safest and most beneficial.
Your surgeon needs a recent Humphrey visual field test, OCT imaging of your optic nerve and macula, intraocular pressure measurements, and a contrast sensitivity assessment. These tests reveal whether your remaining visual function can support a premium IOL or whether a monofocal is the better choice.
An EDOF IOL does not affect your visual field defect itself. The concern is that the reduced contrast from the EDOF optics may make it harder to use your remaining field for daily tasks. Your surgeon weighs this contrast trade-off against the benefit of extended range when making the recommendation.
Your glaucoma treatment continues unchanged after cataract surgery, and your glaucoma specialist monitors your disease. If glaucoma progresses, the IOL remains in place and does not need to be changed. However, advancing field loss may make the reduced contrast of an EDOF lens more noticeable over time compared with what a monofocal would have provided.
Yes. Some surgeons recommend this approach for patients on the borderline between EDOF and monofocal candidacy. The monofocal eye provides maximum contrast, while the EDOF eye extends the intermediate range. Your brain blends the images from both eyes. Your surgeon can discuss whether this combination suits your visual needs and field status.
Your surgeon evaluates your mean deviation on visual field testing, the location of field defects relative to central fixation, your contrast sensitivity measurements, disease stability over the past year, and your optic nerve structure on OCT. Patients with central involvement, mean deviation worse than-10 dB, or declining contrast are typically guided toward monofocal IOLs.
Discuss Your Lens Options with Your Eye Care Team
Your eye doctor and glaucoma specialist can evaluate your visual field status, contrast reserve, and daily visual needs to recommend the IOL that best protects your vision. Schedule a cataract consultation to discuss whether EDOF or monofocal lenses fit your specific eye health profile.